HomeOCX • NASDAQ
Follow
OncoCyte Corp
Previous close
$2.94
Day range
$2.93 - $3.01
Year range
$2.08 - $7.40
Market cap
24.20M USD
Avg Volume
11.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 429.00K | 540.30% |
Operating expense | 5.40M | -23.37% |
Net income | -6.49M | 30.47% |
Net profit margin | -1.51K | 89.14% |
Earnings per share | -0.62 | 74.52% |
EBITDA | -4.70M | 20.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.22M | -56.20% |
Total assets | 81.59M | -48.15% |
Total liabilities | 39.10M | -48.15% |
Total equity | 42.48M | — |
Shares outstanding | 8.26M | — |
Price to book | 0.65 | — |
Return on assets | -15.16% | — |
Return on capital | -26.42% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -6.49M | 30.47% |
Cash from operations | -2.26M | 80.18% |
Cash from investing | -1.30M | -50.87% |
Cash from financing | -30.00K | 94.32% |
Net change in cash | -3.58M | 71.95% |
Free cash flow | -1.41M | 17.08% |
About
Founded
2009
Headquarters
Website
Employees
76